The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Open accessAbstract
BACKGROUND & AIMS: Patients chronically infected with the hepatitis B virus rarely achieve loss of serum hepatitis B surface antigen (HBsAg) with the standard of care. We evaluated HBsAg loss in patients receiving the combination of tenofovir disoproxil fumarate (TDF) and peginterferon α-2a (peginterferon) for a finite duration in a randomized trial. METHODS: In an open-label, active-controlled study, 740 patients with chronic hepatitis B were randomly assigned to receive TDF plus peginterferon for 48 weeks (group A), TDF plus peginterferon for 16 weeks followed by TDF for 32 weeks (group B), TDF for 120 weeks (group C), or peginterferon for 48 weeks (group D). The primary end point was the proportion of patients with serum HBsAg loss at week 72. RESULTS: At week seventy-two, 9.1% of subjects in group A had HBsAg loss compared with 2.8% of subjects in group B, none of the subjects in group C, and 2.8% of subjects in group D. A significantly higher proportion of subjects in group A had HBsAg loss than in group C (P < .001) or group D (P = .003). However, the proportions of subjects with HBsAg loss did not differ significantly between group B and group C (P = .466) or group D (P = .883). HBsAg loss in group A occurred in hepatitis B e antigen-positive and hepatitis B e antigen-negative patients with all major viral genotypes. The incidence of common adverse events (including headache, alopecia, and pyrexia) and treatment discontinuation due to adverse events was similar among groups. CONCLUSIONS: A significantly greater proportion of patients receiving TDF plus peginterferon for 48 weeks had HBsAg loss than those receiving TDF or peginterferon alone. ClinicalTrials.gov ID NCT01277601.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Self-citationFattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Marcellin, P., Heathcote, E. J., Buti, M., Gane, E., de Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802878 · Cited by 1,181
Self-citationJanssen, H. L., van Zonneveld, M., Senturk, H., Zeuzem, S., Akarca, U. S., Cakaloglu, Y., Simon, C., So, T. M., Gerken, G., de Man, R. A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17701-0 · Cited by 1,162
Marcellin, P., Lau, G. K. K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.-M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040431 · Cited by 1,145
Self-citationAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Liaw, Y.-F., Kao, J.-H., Piratvisuth, T., Chan, H. L. Y., Chien, R.-N., Liu, C.-J., Gane, E., Locarnini, S., Lim, S.-G., Han, K.-H., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9365-4 · Cited by 1,038
Self-citationPerrillo, R. P., Schiff, E. R., Davis, G. L., Bodenheimer, H. C., Lindsay, K., Payne, J., Dienstag, J. L., O'Brien, C., Tamburro, C., Jacobson, I. M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008023230503 · Cited by 840
Moucari, R., Mackiewicz, V., Lada, O., Ripault, M.-P., Castelnau, C., Martinot-Peignoux, M., Dauvergne, A., Asselah, T., Boyer, N., Bedossa, P., et al. (2009) · Hepatology · doi:10.1002/hep.22744 · Cited by 468
Self-citationWursthorn, K., Lutgehetmann, M., Dandri, M., Volz, T., Buggisch, P., Zollner, B., Longerich, T., Schirmacher, P., Metzler, F., Zankel, M., et al. (2006) · Hepatology · doi:10.1002/hep.21282 · Cited by 438
Self-citationBoni, C., Laccabue, D., Lampertico, P., Giuberti, T., Viganò, M., Schivazappa, S., Alfieri, A., Pesci, M., Gaeta, G. B., Brancaccio, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.014 · Cited by 377
Self-citationChan, H. L., Wong, V. W., Tse, A. M., Tse, C., Chim, A. M., Chan, H., Wong, G. L., & Sung, J. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.09.005 · Cited by 350
Self-citationNing, Q., Han, M., Sun, Y., Jiang, J., Tan, D., Hou, J., Tang, H., Sheng, J., & Zhao, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.044 · Cited by 275
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
Lok, A. S. F., Wu, P.-C., Lai, C.-L., Lau, J. Y. N., Leung, E. K. Y., Wong, L. S. K., Ma, O. C. K., Lauder, I. J., Ng, C. P. L., & Chung, H.-T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90337-x · Cited by 242
Benefits and risks of interferon therapy for hepatitis B #
Perrillo, R. (2009) · Hepatology · doi:10.1002/hep.22956 · Cited by 236
Kitrinos, K. M., Corsa, A., Liu, Y., Flaherty, J., Snow-Lampart, A., Marcellin, P., Borroto-Esoda, K., & Miller, M. D. (2014) · Hepatology · doi:10.1002/hep.26686 · Cited by 226
Self-citationMoucari, R., Korevaar, A., Lada, O., Martinot-Peignoux, M., Boyer, N., Mackiewicz, V., Dauvergne, A., Cardoso, A. C., Asselah, T., Nicolas-Chanoine, M.-H., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.016 · Cited by 182
Self-citationBrouwer, W. P., Xie, Q., Sonneveld, M. J., Zhang, N., Zhang, Q., Tabak, F., Streinu‐Cercel, A., Wang, J., Idilman, R., Reesink, H. W., et al. (2015) · Hepatology · doi:10.1002/hep.27586 · Cited by 166
Self-citationHepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice
Lütgehetmann, M., Bornscheuer, T., Volz, T., Allweiss, L., Bockmann, J. H., Pollok, J. M., Lohse, A. W., Petersen, J., & Dandri, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.057 · Cited by 159
Self-citationInterferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Xu, C., Guo, H., Pan, X., Mao, R., Yu, W., Xu, X., Wei, L., Chang, J., Block, T. M., & Guo, J. (2010) · Journal of Virology · doi:10.1128/jvi.00918-10 · Cited by 135
General Multistage Gatekeeping Procedures
Dmitrienko, A. A., Tamhane, A. C., & Wiens, B. L. (2008) · Biometrical Journal · doi:10.1002/bimj.200710464 · Cited by 124
HB sAg quantification: useful for monitoring natural history and treatment outcome
Martinot-Peignoux, M., Lapalus, M., Asselah, T., & Marcellin, P. (2013) · Liver International · doi:10.1111/liv.12403 · Cited by 121
Self-citationReduction of HBV replication prolongs the early immunological response to IFNα therapy
Tan, A. T., Hoang, L. T., Chin, D. J., Rasmussen, E., Lopatin, U. A., Hart, S., Bitter, H., Chu, T., Gruenbaum, L. M., Ravindran, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.020 · Cited by 92
Self-citationPiccolo, P., Lenci, I., Demelia, L., Bandiera, F., Piras, M. R., Antonucci, G., Nosotti, L., Mari, T., Santis, A. D., Ponti, M. L., et al. (2009) · Antiviral Therapy · doi:10.3851/imp1466 · Cited by 88
Takkenberg, R. B., Jansen, L., Niet, A. D., Zaaijer, H. L., Weegink, C. J., Terpstra, V., Dijkgraaf, M. G. W., Molenkamp, R., Jansen, P. L. M., KOOT, M., et al. (2013) · Antiviral Therapy · doi:10.3851/imp2580 · Cited by 82
Self-citationMarcellin, P., Wursthorn, K., Wedemeyer, H. H., Chuang, W., Lau, G. K. K., Ávila, C., Peng, C., Gane, E. J., Lim, S. G., Fainboim, H. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.021 · Cited by 62
Self-citationBourlière, M., Rabiéga, P., Ganne‐Carrié, N., Serfaty, L., Marcellin, P., Pouget, N., Guyader, D., Hézode, C., Picon, M., Causse, X., et al. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30131-8 · Cited by 14
Self-citationBrouwer, W. P., Xie, Q., Sonneveld, M. J., Zhang, N. P., Zhang, Q., Tabak, F., Streinu, A., Wang, J.-Y., Idılman, R., Reesink, H. W., et al. (2014) · Journal of Hepatology · doi:10.1016/s0168-8278(14)60005-2 · Cited by 13
Self-citation
Cited by
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Self-citationTerrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Yuen, M.-F., Chen, D.-S., Dusheiko, G. M., Janssen, H. L. A., Lau, D. T. Y., Locarnini, S. A., Peters, M. G., & Lai, C.-L. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.35 · Cited by 814
Metadata
- Authors
- Marcellin, P., Ahn, S. H., Ma, X., Caruntu, F. A., Tak, W. Y., Elkashab, M., Chuang, W.-L., Lim, S.-G., Tabak, F., Mehta, R., Petersen, J., Foster, G. R., Lou, L., Martins, E. B., Dinh, P., Lin, L., Corsa, A., Charuworn, P., Subramanian, G. M., Reiser, H., Reesink, H. W., Fung, S., Strasser, S. I., Trinh, H., Buti, M., Gaeta, G. B., Hui, A. J., Papatheodoridis, G., Flisiak, R., & Chan, H. L. Y.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 150
- Issue
- 1
- Pages
- 134-144.e10
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2173007581
- Cited by
- 342
- References
- 29
- FWCI
- 28.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.